Clinical trial for Obstructive Sleep Apnea
Official title Effect of Transcutaneous Electrical Stimulation on Polysomnographic Parameters in Patients With Obstructive Sleep Apnea
ClinicalTrials.gov ID: NCT07891702
What this study is testing
- What it's testing
- The aim of this study is to assess the impact of transcutaneous electrical stimulation on polysomnographic findings in obstructive sleep apnea patients.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 1 - Adult patients aged 18 years or older. 2- Male or female patients diagnosed with obstructive sleep apnea by baseline overnight polysomnography.
- 3- Patients willing to participate in the study and provide written informed consent.
You likely can't join if
- Patients with central sleep apnea or predominantly central sleep-disordered breathing.
- Patients with significant unstable cardiovascular or respiratory disease that may increase the risk of participation.
- Patients with implanted electronic devices, such as pacemakers or implantable cardioverter-defibrillators.
- Patients with skin lesions, infection, irritation, or other abnormalities at the intended electrode application sites.
- Patients with neurological or neuromuscular disorders that significantly affect upper airway muscle function.
- Patients with a history of upper airway surgery that substantially alters upper airway anatomy, if this may interfere with study assessment.
See the full eligibility criteria
- 1 - Adult patients aged 18 years or older. 2- Male or female patients diagnosed with obstructive sleep apnea by baseline overnight polysomnography.
- 3- Patients willing to participate in the study and provide written informed consent.
- Patients with central sleep apnea or predominantly central sleep-disordered breathing.
- Patients with significant unstable cardiovascular or respiratory disease that may increase the risk of participation.
- Patients with implanted electronic devices, such as pacemakers or implantable cardioverter-defibrillators.
- Patients with skin lesions, infection, irritation, or other abnormalities at the intended electrode application sites.
- Patients with neurological or neuromuscular disorders that significantly affect upper airway muscle function.
- Patients with a history of upper airway surgery that substantially alters upper airway anatomy, if this may interfere with study assessment.
- Patients unable to tolerate electrical stimulation or complete the required polysomnography sessions.
- Patients who decline to participate or withdraw their informed consent.
The study team makes the final eligibility decision.
Where it is enrolling
- Al Mansurah, Dakahlia Governorate, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Al Mansurah, Dakahlia Governorate, Egypt. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.